Zions Bancorporation’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-149
| Closed | -$27K | – | 1081 |
|
|
2021
Q2 | $27K | Buy |
149
+3
| +2% | +$544 | ﹤0.01% | 533 |
|
|
2021
Q1 | $22K | Sell |
146
-3,972
| -96% | -$599K | ﹤0.01% | 560 |
|
|
2020
Q4 | $643K | Sell |
4,118
-9
| -0.2% | -$1.41K | 0.08% | 104 |
|
|
2020
Q3 | $472K | Sell |
4,127
-273
| -6% | -$31.2K | 0.07% | 117 |
|
|
2020
Q2 | $494K | Buy |
4,400
+1,060
| +32% | +$119K | 0.07% | 104 |
|
|
2020
Q1 | $300K | Buy |
3,340
+1,420
| +74% | +$128K | 0.05% | 128 |
|
|
2019
Q4 | $208K | Sell |
1,920
-164
| -8% | -$17.8K | 0.03% | 216 |
|
|
2019
Q3 | $204K | Buy |
+2,084
| New | +$204K | 0.03% | 244 |
|
|
2018
Q4 | – | Sell |
-379
| Closed | -$53K | – | 814 |
|
|
2018
Q3 | $53K | Buy |
+379
| New | +$53K | 0.01% | 324 |
|
|
2017
Q4 | – | Sell |
-655
| Closed | -$92K | – | 1030 |
|
|
2017
Q3 | $92K | Buy |
655
+636
| +3,347% | +$89.3K | 0.01% | 447 |
|
|
2017
Q2 | $2K | Sell |
19
-51
| -73% | -$5.37K | ﹤0.01% | 618 |
|
|
2017
Q1 | $7K | Sell |
70
-53
| -43% | -$5.3K | ﹤0.01% | 454 |
|
|
2016
Q4 | $15K | Sell |
123
-32
| -21% | -$3.9K | ﹤0.01% | 440 |
|
|
2016
Q3 | $19K | Buy |
155
+54
| +53% | +$6.62K | ﹤0.01% | 389 |
|
|
2016
Q2 | $13K | Sell |
101
-64
| -39% | -$8.24K | ﹤0.01% | 416 |
|
|
2016
Q1 | $24K | Buy |
165
+3
| +2% | +$436 | ﹤0.01% | 351 |
|
|
2015
Q4 | $23K | Sell |
162
-5
| -3% | -$710 | ﹤0.01% | 335 |
|
|
2015
Q3 | $29K | Buy |
+167
| New | +$29K | 0.01% | 290 |
|
|
2015
Q2 | – | Sell |
-145
| Closed | -$25K | – | 800 |
|
|
2015
Q1 | $25K | Buy |
+145
| New | +$25K | ﹤0.01% | 329 |
|